wearemetech

The second European Medtech Week from 13-17 June was a platform actively leveraged by all stakeholders to discuss the potential of MedTech. Over 100 events took place in 18 European countries as part of MedTech Week, with the medtech industry and our various partners discussing topics that were high on their national agendas. National medtech associations and individual companies demonstrated how medical technologies save and transform peoples’ lives. It was great to see healthcare professionals and patients from very different backgrounds and regions across Europe sharing their first-hand, insightful experiences, as well as their views on what needs to change in order to improve their daily lives. One of the topics that was discussed in a number of countries was the role and potential of eHealth. This is a subject very close to my heart because I believe it will be a key enabler for moving healthcare in the right direction. Based on the feedback from a range of events across Europe, we can see there seems to be strong agreement amongst all stakeholders that three important issues need to be addressed in order to use the full potential of eHealth: - We need a safe regulatory environment for e-products and services - We need to adapt funding schemes appropriately to allow access to e-products and e-services - We must move forward in terms of interoperability of products, services and systems Clear and timely action on these areas would allow eHealth to facilitate solutions to a range of healthcare challenges: using big data, embracing health apps, and deploying remote solutions in the most efficient way for the benefit of patients and doctors. I believe this year’s European Medtech Week showed that our industry has grown up and is now a reliable and relevant partner seeking to be a responsible participant...
Do you remember the last time you have used a medical technology product? I think a lot of people, including myself, will answer that it was quite recent. In fact, medical technology is all around us - diagnosing, monitoring and treating virtually every disease or condition. And in the 2nd edition of the European MedTech Week from 13 to 17 of June 2016, everyone will be able to explore how medical technologies help in saving and transforming our daily lives. What is MedTech Week? European MedTech Week aims to raise awareness and create a conversation about medical technology. Innovative companies, national associations and stakeholders in health, including patients, professionals, and carers, will tell how devices and diagnostic tests are transforming our lives and our health. At the first ever MedTech Week last year, we celebrated the value of medical technology via radio programmes, scientific conferences, press interviews, patient testimonials, and museum donations. You can see a summary of our 2015 activities in the MedTech Week magazine . What will happen during MedTech Week 2016? This year, we’ll build on the last edition’s success and promote the diversity, innovation and creativity of the sector. Together with our members, we are putting in place policy roundtables, visits to manufacturing sites, partnerships with patient groups and conversations on social media. There will also be a series of interviews with experts who will give their insights into how medical technology can care for patients and transform lives. You can visit the new website – www.medtechweek.eu - to browse all events happening across Europe during the week. How can I get involved? If you are a patient, health advocate, researcher, healthcare professional or stakeholder with an interest in medical devices and diagnostic tests, we want you to come on board. You can share your stories...
At W.L. Gore we took the decision to review our educational strategy well before the recommendation of the EDMA and Eucomed Boards to phase-out direct sponsorship of Healthcare Professionals (HCPs) to third party organised educational events was announced. We did this as our business leaders were getting increasingly concerned about the complexities of doing business across regions worldwide and being aware of all the issues that could arise. In our company, fairness is one of the core values, and we consider fairness to our customers as part of our ethos. Discussions around medical education were originally business led, with representatives from all parts of the business of our company contributing. Then compliance and legal professionals joined the conversation. As we talked and talked, we realised we had to answer the question - why do we support the medical education of Healthcare Professionals and for what reason? This helped us come up with a new, refocused educational strategy that took into account the changing environment and the modern world in which we operate. As a result we did reconfirm our intention to provide education, but we reviewed the best and most efficient way in which this could be done. The debate led us to introduce a shift from direct sponsoring of HCPs to third party organised educational events to grants. Was this tough? Yes, particularly as in some areas W.L. Gore was the first to introduce this concept. Both internally and externally some struggled with the concept. However with clear explanation and our conviction that this was the right way forward we started to see a change in attitude. We now find a system based on grants allows more forward planning, as we provide grants for a period of up to a year. Generally a broader group within the chosen institution...
We are MedTech is a blog series highlighting employees of the medical technology industry and their work. Meet Ludovica Moccaldi. As a student I envisioned myself pursuing a job that had a positive impact on people’s lives and I am proud to be able to say that I have succeeded achieving this early in my career. I’ve found through my career that working in the MedTech industry makes you feel like you are part of something bigger, something meaningful, and something that touches people’s lives on a daily basis. Our work has a positive influence on the lives and wellbeing of thousands of patients and, in my opinion, that’s the best reward you can possibly receive. As a member of a health economic and reimbursement department at a major medical device manufacturer, my main responsibility is ensuring patients have access to world-class technologies. When I’m asked about what I do on a day-to-day basis, I always refer to my employers focus on ‘patient access’ instead of ‘market access.’ I do this because that’s why we collectively put every ounce of our energy and effort into our work: we want patients to have greater access to innovative technologies that can improve or save their lives. As in other sectors, working in the MedTech industry implies overcoming certain obstacles. We are continuously referred to as one of the most innovative and dynamic sectors in Europe. In many ways, it’s difficult for the wide-range of diverse stakeholders, and even the healthcare system itself, to keep up with the fast-pace environment that innovation brings to our industry. Our role is to educate and inform the various decision makers with factual, clinical and economic data that demonstrate the benefits of new therapies. Every day, I seek to work with key decision makers, or influencers, that...